第五巡回上诉法院法官质疑HHS在Medicare Advantage审计诉讼中的论据
STAT+: Judges skewer HHS arguments in hearing over Medicare Advantage audits lawsuit
美国第五巡回上诉法院三位法官在Humana v. Kennedy案听证会上,认为HHS关于Medicare Advantage计划审计规则(RADV规则)的论据难以成立。法官们表现出再次推翻该规则的倾向,此前联邦地区法院已于2025年9月认定HHS最终规则偏离提案规则且未给予利益相关方适当通知。
![]()
By Tara Bannow
Oct. 5, 2026
Hospitals and Insurance Reporter
Tara covers the business of health care. Her stories focus on hospitals, doctors, and how their business practices affect patients — especially when private equity gets involved. She also writes about health insurance and ideas for improving our broken health system. You can reach Tara on Signal at tarabannow.70.
Federal appeals court judges didn’t take kindly to the Trump administration’s arguments Monday in a hearing on Humana’s lawsuit against the government over its rules for auditing Medicare Advantage plans.
The country’s second largest Medicare Advantage insurer argued in its 2023 lawsuit, Humana v. Kennedy, that the Health and Human Services Department’s final rule for auditing Medicare Advantage plans diverged significantly from its proposed rule and that stakeholders weren’t given proper notice and opportunity to comment on the change, which they said would be detrimental to insurers.
In September 2025, a federal judge agreed and invalidated the rule, called the risk adjustment data validation, or RADV, rule. HHS appealed in November. During Monday’s oral arguments, a three-judge panel of the U.S. Court of Appeals for the Fifth Circuit seemed poised to toss the rule out, again.
STAT+ Exclusive Story
Already have an account? Log in

This article is exclusive to STAT+ subscribers
Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
来源:STAT 主站 · statnews.com